Themis Medicare Limited (THEMISMED) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Themis Medicare Limited (THEMISMED) has a cash flow conversion efficiency ratio of -0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-14.84 Million ≈ $-160.49K USD) by net assets (Rs3.80 Billion ≈ $41.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Themis Medicare Limited to measure how much of total assets are equity-financed.
Themis Medicare Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Themis Medicare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check THEMISMED cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Themis Medicare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Themis Medicare Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Azevedo & Travassos S.A
SA:AZEV3
|
0.195x |
|
Shin Foong Specialty and Applied Materials Co
TW:6582
|
0.000x |
|
Seah Spe Steel
KO:019440
|
0.038x |
|
GENOR BIOPHARMA DL-00002
F:67N0
|
N/A |
|
Tunghsu Azure Renewable Energy Co Ltd
SHE:000040
|
0.016x |
|
Kangnam Jevisco Co Ltd
KO:000860
|
0.000x |
|
TTEC Holdings Inc
NASDAQ:TTEC
|
0.269x |
|
Duro Felguera
MC:MDF
|
0.033x |
Annual Cash Flow Conversion Efficiency for Themis Medicare Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Themis Medicare Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Themis Medicare Limited stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs4.03 Billion ≈ $43.54 Million |
Rs347.10 Million ≈ $3.75 Million |
0.086x | +47.37% |
| 2024-03-31 | Rs3.78 Billion ≈ $40.84 Million |
Rs220.94 Million ≈ $2.39 Million |
0.059x | +23.40% |
| 2023-03-31 | Rs3.39 Billion ≈ $36.71 Million |
Rs160.93 Million ≈ $1.74 Million |
0.047x | -60.37% |
| 2022-03-31 | Rs2.87 Billion ≈ $31.09 Million |
Rs343.94 Million ≈ $3.72 Million |
0.120x | -54.12% |
| 2021-03-31 | Rs2.19 Billion ≈ $23.63 Million |
Rs569.75 Million ≈ $6.16 Million |
0.261x | +14440.88% |
| 2020-03-31 | Rs1.83 Billion ≈ $19.79 Million |
Rs3.28 Million ≈ $35.49K |
0.002x | -97.41% |
| 2019-03-31 | Rs1.58 Billion ≈ $17.09 Million |
Rs109.23 Million ≈ $1.18 Million |
0.069x | +48.70% |
| 2018-03-31 | Rs1.69 Billion ≈ $18.26 Million |
Rs78.47 Million ≈ $848.62K |
0.046x | +152.43% |
| 2017-03-31 | Rs1.20 Billion ≈ $13.03 Million |
Rs-106.78 Million ≈ $-1.15 Million |
-0.089x | -128.86% |
| 2016-03-31 | Rs788.89 Million ≈ $8.53 Million |
Rs242.32 Million ≈ $2.62 Million |
0.307x | +0.33% |
| 2015-03-31 | Rs589.08 Million ≈ $6.37 Million |
Rs180.34 Million ≈ $1.95 Million |
0.306x | +188.73% |
| 2014-03-31 | Rs561.85 Million ≈ $6.08 Million |
Rs59.57 Million ≈ $644.27K |
0.106x | +25.17% |
| 2013-03-31 | Rs537.17 Million ≈ $5.81 Million |
Rs45.51 Million ≈ $492.12K |
0.085x | +132.21% |
| 2012-03-31 | Rs580.79 Million ≈ $6.28 Million |
Rs-152.73 Million ≈ $-1.65 Million |
-0.263x | -639.73% |
| 2011-03-31 | Rs910.26 Million ≈ $9.84 Million |
Rs44.35 Million ≈ $479.64K |
0.049x | +16.28% |
| 2010-03-31 | Rs833.43 Million ≈ $9.01 Million |
Rs34.92 Million ≈ $377.67K |
0.042x | +145.22% |
| 2009-03-31 | Rs918.65 Million ≈ $9.93 Million |
Rs-85.13 Million ≈ $-920.63K |
-0.093x | -9.87% |
| 2008-03-31 | Rs845.93 Million ≈ $9.15 Million |
Rs-71.35 Million ≈ $-771.58K |
-0.084x | -184.24% |
| 2007-03-31 | Rs691.60 Million ≈ $7.48 Million |
Rs69.24 Million ≈ $748.82K |
0.100x | +155.05% |
| 2006-03-31 | Rs605.21 Million ≈ $6.55 Million |
Rs23.76 Million ≈ $256.92K |
0.039x | -- |
About Themis Medicare Limited
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including anti-tuberculosis, analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic,… Read more